CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash Flows From Operating Activities:
Net loss before income taxes	$ (6,719,563)	$ (5,568,666)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	370,151	827,701
Change in fair value of derivative instrument-warrants	(530,445)	(4,645,829)
Change in fair value of contingent consideration	(160,000)	85,000
Change in fair value of debt	(31,948)
Noncash interest expense	31,948
Change in deferred tax liability	(536,000)
Deferred financing costs	(13,781)
Depreciation and amortization expenses	9,505	14,854
Loss on the sale of assets	4,474
Changes in operating assets and liabilities:
Accounts payable and accrued expenses	655,652	(279,277)
Deferred rent liability	7,406
Prepaid expenses and other assets	(97,100)	102,000
Net Cash Used in Operating Activities	(7,009,701)	(9,464,217)
Cash Flows From Investing Activities:
Purchases of property and equipment		(2,425)
Proceeds from the sale of fixed assets	900
Net Cash Provided by (Used in) Investing Activities	900	(2,425)
Cash Flows From Financing Activities:
Proceeds from the issuance of common stock	1,635,140	13,563,159
Issuance of common stock via stock option exercises		(1,754,588)
Proceeds from the exercise of warrants		85,000
Proceeds from the exercise of stock options		4,098
Proceeds from debt financing	2,000,000
Net Cash Provided by Financing Activities	3,635,140	11,897,669
Net (decrease) increase in cash	(3,373,661)	2,431,027
Cash at beginning of period	5,954,017	10,551,721
Cash at end of period	2,580,356	12,982,748
Supplementary Disclosure Of Non-Cash Financing Activities:
Stock issued to employees in lieu of cash payment for accrued bonuses	259,598
Reclass of derivative liability for warrant exercise		75,417
Conversion of Series A convertible preferred stock	$ 184,320	190,980
Fair value of warrants issued in conjunction with common stock offering		$ 3,976,501